Skip to main content
Premium Trial:

Request an Annual Quote

Health Discovery Raises $3M Through Stock Offering

NEW YORK, March 23 (GenomeWeb News) - Health Discovery, a Savannah, Ga.-based pharmacogenomics company, has raised $3 million through a stock offering, according to a report by a local Savannah business publication.

 

The Business Reporter today reported that Health Discovery's stock offering closed $10,000 short of $3 million, and that the firm would be pumping the revenue into its development of biomarkers and pathways.


Health Discovery CEO and Chairman Stephen Barnhill told The Business Reporter that the 2-year-old firm would be adding 10 workers to the company's staff over the following year. Health Discovery currently employs 15 people at offices in Georgia, Texas, and California, and has registered nearly 80 patents according to The Business Reporter.

The company announced partnerships with Stanford University and the MD Anderson Cancer Center last year.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.